期刊文献+

Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography 被引量:7

下载PDF
导出
摘要 Background The correlation among the ratios of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol(LDL-C/HDL-C), total cholesterol/high-density lipoprotein cholesterol(TC/HDL-C) and thin-cap fibroatheroma has not yet been established. Methods It was a single center, retrospective observational study. In total, we recruited 421 patients(82.4% men;mean age 65.73 ± 10.44 years) with one culprit vessel which determined by intravascular optical coherence tomography(OCT). The thinnest-capped fibroatheroma(TCFA) group was defined as lipid contents in > 2 quadrants, with the thinnest fibrous cap measuring less than 65 μm. Univariate and multivariate logistic regression were carried out to explore the relationship between lipoprotein ratios, TCFA and other characteristics of plaque. To compare different ratios, the area under curve(AUC) of receiver-operating characteristic(ROC) curve was assessed. Results OCT was performed in 421 patients(TCFA group(n = 109), non-TCFA group(n = 312)). LDL-C/HDL-C in the TCFA group was significantly higher than in the non-TCFA group(2.95 ± 1.20 vs. 2.43 ± 0.92, P < 0.05), as was TC/LDL in TCFA and non-TCFA group(4.57 ± 1.58 vs. 4.04 ± 1.13, P < 0.05). Both LDL-C/HDL-C(OR: 1.002(1.002-1.003), P < 0.05) and TC/HDL-C(OR: 1.001(1.001-1.004), P < 0.05) were considered independent factors for the prediction of TCFA according to the logistic regression. Based on the AUC comparison, LDL-C/HDL-C and TC/HDL-C had no significant difference statistically(LDL-C/HDL-C AUC: 0.63;TC/HDL-C AUC: 0.61;P = 0.10) for the prediction of TCFA. Conclusions LDL-C/HDL-C and TC/HDL-C could be the independent factors for predicting the presence of TCFA, indicating coronary plaque vulnerability in CAD patients. Moreover, TC/HDL-C also showed a comparative performance for the prediction of TCFA as LDL-C/HDL-C.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2020年第11期666-673,共8页 老年心脏病学杂志(英文版)
基金 supported by Zhejiang Natural Science Foundation (LY18H020007 and LQ16H020001) National Natural Science Foundation of China (81500212 and 81800212)。
  • 相关文献

参考文献1

二级参考文献44

  • 1Frick MH;Elo O;Haapa K.Helsinki Heart Study:primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia.Safety of treatment,changes in risk factors,and incidence of coronary heart disease,1987(20).
  • 2Ginsberg HN,Elam MB,Lovato LC,Crouse JR,Leiter LA,Linz P,Friedewald WT,Buse JB,Gerstein HC,Probstfield J,Grimm RH,Ismail-Beigi F,Bigger JT,Goff DC,Cushman WC,Simons-Morton DG,Byington RP.Effects of combination lipid therapy in type 2 diabetes mellitus. The New England Journal of Medicine . 2010
  • 3Filippatos TD,Liberopoulos EN,Kostapanos M,Gazi IF,Papavasiliou EC,Kiortsis DN,Tselepis AD,Elisaf MS.The effects of orlistat and fenofibrate,alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome. Diabetes Obesity and Metabolism . 2008
  • 4http: //www.cori.org/ .
  • 5Boden WE,Probstfield JL,Anderson T,Chaitman BR,Desvignes-Nickens P,Koprowicz K,McBride R,Teo K,Weintraub W.Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. The New England Journal of Medicine . 2011
  • 6Hisashi Shinkai.Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases[J]. Vascular Health and Risk Management . 2012 (default)
  • 7Sarah Parish,Alison Offer,Robert Clarke,Jemma C. Hopewell,Michael R. Hill,James D. Otvos,Jane Armitage,Rory Collins.Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study[J]. Circulation . 2012 (20)
  • 8Laurent Camont,M. John Chapman,Anatol Kontush.Biological activities of HDL subpopulations and their relevance to cardiovascular disease[J]. Trends in Molecular Medicine . 2011 (10)
  • 9Benoit J. Arsenault,Philip Barter,David A. DeMicco,Weihang Bao,Gregory M. Preston,John C. LaRosa,Scott M. Grundy,Prakash Deedwania,Heiner Greten,Nanette K. Wenger,James Shepherd,David D. Waters,John J.P. Kastelein.Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients by Lipid and Nonlipid Biomarkers[J]. Journal of the American College of Cardiology . 2011 (1)
  • 10Eugene APodrez.Anti‐oxidant properties of high‐density lipoprotein and atherosclerosis[J]. Clinical and Experimental Pharmacology and Physiology . 2010 (7)

同被引文献51

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部